A detailed history of Tradewinds Capital Management, LLC transactions in Incyte Corp stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 25 shares of INCY stock, worth $1,588. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Holding current value
$1,588
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$51.18 - $63.75 $1,279 - $1,593
25 New
25 $1,000
Q4 2021

Feb 02, 2022

SELL
$63.34 - $74.11 $12,668 - $14,822
-200 Closed
0 $0
Q2 2020

Aug 11, 2020

SELL
$74.18 - $108.93 $593 - $871
-8 Reduced 3.85%
200 $21,000
Q1 2020

May 11, 2020

BUY
$63.18 - $85.97 $505 - $687
8 Added 4.0%
208 $15,000
Q4 2017

Feb 01, 2018

BUY
$93.56 - $116.6 $18,712 - $23,320
200
200 $19,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Tradewinds Capital Management, LLC Portfolio

Follow Tradewinds Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.